Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Bodegard

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 10, 2005
[Long term prognosis in relation to the presence of systolic heart murmurs in healthy middle-aged men]Geeta Gulati, Johan Bodegard
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 14, 2004
[Exercise ECG]Gunnar Erikssen, Johan Bodegard, Jan Erikssen
Therapeutic Advances in Psychopharmacology|February 6, 2015
Characteristics of bipolar disorder patients treated with immediate- and extended-release quetiapine in a real clinical setting: a longitudinal, cohort study of 1761 patientsAndreas Carlborg, Marcus Thuresson, Lena Ferntoft, et al.
Bipolar Disorders|July 25, 2014
Population study of disease burden, management, and treatment of bipolar disorder in Sweden: a retrospective observational registry studyAndreas Carlborg, Lena Ferntoft, Marcus Thuresson, et al.
European Heart Journal|April 28, 2005
Reasons for terminating an exercise test provide independent prognostic information: 2014 apparently healthy men followed for 26 yearsJohan Bodegard, Gunnar Erikssen, Jørgen V Bjørnholt, et al.
Diabetes Research and Clinical Practice|January 6, 2017
Second line initiation of insulin compared with DPP-4 inhibitors after metformin monotherapy is associated with increased risk of all-cause mortality, cardiovascular events, and severe hypoglycemiaThomas Nyström, Johan Bodegard, David Nathanson, et al.
Diabetes, Obesity & Metabolism|January 25, 2017
Novel oral glucose-lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetesThomas Nyström, Johan Bodegard, David Nathanson, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|August 5, 2004
Symptom-limited exercise testing, ST depressions and long-term coronary heart disease mortality in apparently healthy middle-aged menJohan Bodegard, Gunnar Erikssen, Jørgen V Bjørnholt, et al.
Diabetes Research and Clinical Practice|June 23, 2016
Sulphonylurea compared to DPP-4 inhibitors in combination with metformin carries increased risk of severe hypoglycemia, cardiovascular events, and all-cause mortalityJan W Eriksson, Johan Bodegard, David Nathanson, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 4, 2011
Cardiovascular events in subgroups of patients during primary treatment of hypertension with candesartan or losartanDavid Russell, Jan Stålhammar, Johan Bodegard, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 10, 2005
[Long term prognosis in relation to the presence of systolic heart murmurs in healthy middle-aged men]Geeta Gulati, Johan Bodegard
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 14, 2004
[Exercise ECG]Gunnar Erikssen, Johan Bodegard, Jan Erikssen
Therapeutic Advances in Psychopharmacology|February 6, 2015
Characteristics of bipolar disorder patients treated with immediate- and extended-release quetiapine in a real clinical setting: a longitudinal, cohort study of 1761 patientsAndreas Carlborg, Marcus Thuresson, Lena Ferntoft, et al.
Bipolar Disorders|July 25, 2014
Population study of disease burden, management, and treatment of bipolar disorder in Sweden: a retrospective observational registry studyAndreas Carlborg, Lena Ferntoft, Marcus Thuresson, et al.
European Heart Journal|April 28, 2005
Reasons for terminating an exercise test provide independent prognostic information: 2014 apparently healthy men followed for 26 yearsJohan Bodegard, Gunnar Erikssen, Jørgen V Bjørnholt, et al.
Diabetes Research and Clinical Practice|January 6, 2017
Second line initiation of insulin compared with DPP-4 inhibitors after metformin monotherapy is associated with increased risk of all-cause mortality, cardiovascular events, and severe hypoglycemiaThomas Nyström, Johan Bodegard, David Nathanson, et al.
Diabetes, Obesity & Metabolism|January 25, 2017
Novel oral glucose-lowering drugs are associated with lower risk of all-cause mortality, cardiovascular events and severe hypoglycaemia compared with insulin in patients with type 2 diabetesThomas Nyström, Johan Bodegard, David Nathanson, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|August 5, 2004
Symptom-limited exercise testing, ST depressions and long-term coronary heart disease mortality in apparently healthy middle-aged menJohan Bodegard, Gunnar Erikssen, Jørgen V Bjørnholt, et al.
Diabetes Research and Clinical Practice|June 23, 2016
Sulphonylurea compared to DPP-4 inhibitors in combination with metformin carries increased risk of severe hypoglycemia, cardiovascular events, and all-cause mortalityJan W Eriksson, Johan Bodegard, David Nathanson, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 4, 2011
Cardiovascular events in subgroups of patients during primary treatment of hypertension with candesartan or losartanDavid Russell, Jan Stålhammar, Johan Bodegard, et al.
Pageof 5